Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this exciting learning session on managing Ph negative Acute lymphoblastic leukemia in adults.
Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach complete remission.
Ph-positive ALL is a special type of ALL in which a genetic mutation is observed in the Philadelphia chromosome. In the case of Ph-negative ALL, genetic disparities are also observed and most importantly in Ph neg ALL there is a disproportionate survival rate among the patients.
Managing Ph neg ALL often becomes difficult, however, the procedures of management of Philadelphia chromosome (Ph)–negative acute lymphoblastic leukemia (ALL) have changed dramatically in recent years leading to a positive vibe for the situation.
Therefore, have overall knowledge regarding the management of Ph negative ALL. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.
2.
Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.
3.
CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma
4.
Virtual Reality Travel Reduces Cancer Pain.
5.
The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.
1.
The Importance of Understanding Carboxyhemoglobin Levels in the Body: A Comprehensive Guide
2.
Unleashing the Power of Immune Triads: A Novel Approach to Cancer Immunotherapy
3.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
4.
Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown
5.
Unlocking the Mysteries of Synovial Sarcoma: A New Hope for Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
5.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation